Iscucin Mali St.A ampoules, 10x1 ml

Areas of application

Iscucin Mali Strength A, a liquid dilution for injection, is used in accordance with anthroposophical knowledge of humanity and nature.The areas of application include the stimulation of form and integration forces to dissolve and reintegrate independent growth processes.This includes the treatment of malignant tumor diseases, including those with accompanying disorders of the blood-forming organs, benign tumor diseases, defined precancerous lesions, as well as the prevention of recurrence after tumor operations.It is also used for chronic cross-border diseases such as Crohn's disease or chronic joint diseases.

Composition

Each ampoule of Iscucin Mali Strength A contains 1 ml of Viscum album (Mali) e planta tota K Dil.Strength A (HAB, Vs. 38).

Contraindications

Iscucin Mali must not be used in cases of known allergy to mistletoe preparations, acute inflammatory or highly febrile diseases, chronic granulomatous diseases, florid autoimmune diseases and those under immunosuppressive therapy, as well as in hyperthyroidism with tachycardia.

Precautions and warnings

In the case of primary brain and spinal cord tumors or intracranial metastases with a risk of increased intracranial pressure, the preparations should only be administered according to strict indications and under close clinical control.Effects of the drug on pregnancy, development of the unborn child, birth and development of the child after birth have not been studied.Caution is advised when used during pregnancy and breastfeeding.There is no experience with regard to impairment of the ability to drive or use machines.

Interactions

There are no studies available on interactions with other immunomodulating substances.If appropriate preparations are used promptly, careful dosing and monitoring of appropriate immune indicators is recommended.

Dosage and method of administration

The dosage is carried out individually according to the doctor's instructions.The treating doctor decides on the duration of use.The duration of use is in principle not limited and depends on the respective risk of recurrence and the individual condition or findings of the patient.It should last for several years, with breaks of increasing length as a rule.

Side effects

At the beginning of therapy, a slight increase in body temperature and local inflammatory reactions at the subcutaneous injection site may occur.Temporary mild swelling of regional lymph nodes is also possible.If there is a fever over 38°C or major local reactions over 5 cm in diameter, the next injection should only be given after these symptoms have subsided and at a reduced strength or dose.Localized or systemic allergic or allergoid reactions may occur, requiring discontinuation of the product and initiation of medical therapy.Excessive local reactions can be avoided by using a lower strength of the preparation or a smaller amount of the dose.

Notes

No prescription is required for this product.Further information can be found in the package leaflet.

Address of the provider/manufacturer

WALA Remedy GmbH
Dorfstrasse 1
73087 Bad Boll / Eckwälden